Read more

December 02, 2019
1 min read
Save

Top stories in cardiology include highlights from AHA’s Scientific Sessions

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Most of last week’s top stories in cardiology were from Healio’s live coverage of the American Heart Association’s Scientific Sessions, which recently wrapped up in Philadelphia.

Data presented at the meeting suggest that a high CVD risk may also mean a high cancer risk for patients, and researchers also found a link between early menopause and the risk for CVD.

High CVD risk confers greater odds of cancer

People at high risk for CVD, as assessed by risk factors, 10-year atherosclerotic CVD risk score and biomarkers, also have elevated risk for cancer, research indicated. Read more.

Early menopause raises risk for CVD

In a new study, women with natural and surgical premature menopause before age 40 years had a small but significantly elevated risk for a variety of CVDs, researchers reported. Read more.

Rilonacept improves outcomes in recurrent pericarditis

Rilonacept in patients with recurrent pericarditis led to improvements in clinical and patient-reported measures as soon as after the first injection, data indicated. Read more.

Cardiac arrest survival lower on weekends

Individuals who experience out-of-hospital cardiac arrest are less likely to survive to hospital admission on weekends compared with weekdays, findings showed. Read more.

1.5 million US patients miss doses of atherosclerotic CVD medication due to cost

Approximately 2.2 million, or 13%, of patients with atherosclerotic CVD experience cost-related nonadherence to prescribed medication in the U.S. and approximately 9% take lower than the prescribed dose, according to findings published in Circulation. Read more.